Shuttle pharmaceuticals inc stock
WebMar 11, 2024 · Complete Shuttle Pharmaceuticals Holdings Inc. stock information by Barron's. View real-time SHPH stock price and news, along with industry-best analysis. Web2 days ago · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and …
Shuttle pharmaceuticals inc stock
Did you know?
WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. ... Stock prices can fluctuate wildly, and analyst ratings are provided to help self-directed traders evaluate securities. WebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company ...
WebMar 30, 2024 · Detailed statistics for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock, including valuation metrics, financial numbers, share information and more. WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
WebAug-30-22 04:40PM. Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering. PR Newswire. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. WebSep 6, 2024 · PR Newswire. ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on ...
WebApr 7, 2024 · Shuttle Pharmaceuticals Holdings Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. There are not analysts providing consensus earnings estimates for the current fiscal year. Shuttle Pharmaceuticals Holdings Inc does not currently pay a dividend.
WebMar 3, 2024 · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. derecho a llaves minimarketWebFeb 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. derecho a informarsechronicles 1992 2004WebThe Company was originally founded as Shuttle Pharmaceuticals, LLC in December 2012 in the State of Maryland. In June 2024, Shuttle Pharmaceuticals, Inc. became a wholly owned subsidiary of Shuttle Pharmaceuticals Holdings, Inc., a State of Delaware corporation. chronicles 16 27WebMar 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and … derechoamorir.orgWebApr 6, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) NASDAQ: SHPH · IEX Real-Time Price · USD. Add to Watchlist 1.39-0.06 (-4.14%) At close: Apr 6, 2024, 4:00 PM. 1.38 ... No financial forecasts available for this stock Revenue Forecast. No data available. Revenue Growth. No data available. EPS Forecast. No data available. chronicles 17WebMar 30, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, ... Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $1.18 and its highest was $126.26 in the past 12 months. derecho al aborto onu